Effect of Elagolix in Women with Moderate to Severe Pelvic Tenderness or Induration: Results from Elaris EM-l and EM-II Clinical Trials

Sawsan As‐Sanie, Sukhbir S. Singh, Andrew W. Horne, Maurício Simões Abrão, Sarah J. Cross, K. Gordon, Horia Ijacu, Yilin Song, Jorge F. Carrillo
In: Journal of Minimally Invasive Gynecology · 2020 · vol. 27(7) , pp. S44 · doi:10.1016/j.jmig.2020.08.371 · W3094722696
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-07, 2026-07-09 ⓘ

Elagolix significantly reduced pelvic tenderness and induration in women with endometriosis, demonstrating efficacy in treating moderate to severe symptoms in the Elaris EM-I and EM-II trials.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK